We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,985.00
Bid: 6,984.00
Ask: 6,986.00
Change: 40.00 (0.58%)
Spread: 2.00 (0.03%)
Open: 7,025.00
High: 7,075.00
Low: 6,944.00
Yest. Close: 6,945.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LONDON MARKET OPEN: Stocks Down; US Accuses China Of Reneging On Trade

LONDON (Alliance News) - Stock prices in London opened lower on Tuesday after the US-China trade war threatened to reignite over the long bank holiday weekend in the UK. Top economics advisers to

7 May 19 08:54

TOP NEWS: Astra Reports Positive Trial Results For Leukaemia Drug

LONDON (Alliance News) - AstraZeneca PLC on Tuesday said trial results of Calquence showed significant increase in time patients lived without progression of chronic lymphocytic leukaemia in the a

7 May 19 08:50

AstraZeneca leukaemia drug trial reports positive results

(Sharecast News) - AstraZeneca said a phase three trial of its Calquence treatment for chronic lymphocytic leukaemia had shown a "statistically-significant and clinically-meaningful improvement in progression-free survival" compared with a combination regimen.

7 May 19 08:01

LONDON MARKET PRE-OPEN: Smurfit Kappa And HSBC Start 2019 Well

LONDON (Alliance News) - Stocks in London are called for a marginally higher start on Friday, as Smurfit Kappa joined HSBC in reported a strong first three months

3 May 19 07:38

AstraZeneca gets FDA approval for 'Qternmet XR'

(Sharecast News) - AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) has approved 'Qternmet XR' (dapagliflozin, saxagliptin and metformin hydrochloride) extended release tablets as an oral adjunct treatment to diet and exercise, to improve glycaemic control in adults with type-2 diabetes (T2D).

3 May 19 07:27

DIRECTOR DEALINGS: AstraZeneca Boss Soriot, Non-Execs Buys Shares

LONDON (Alliance News) - AstraZeneca PLC said Wednesday Chief Executive Officer Pascal Soriot and three non-executives at the drug maker bought shares in the FTSE 100-listed firm in a series of on

1 May 19 13:56

Tuesday broker round-up

(Sharecast News) - Nexus: Numis downgrades to add with a target price of 165p.

30 Apr 19 13:23

Monday broker round-up

(Sharecast News) - HomeServe: HSBC downgrades to reduce with a target price of 1,000p.

29 Apr 19 13:25

Deutsche stands by 'top pick' rating on AstraZeneca

(Sharecast News) - Analysts at Deutsche Bank reiterated their 'buy' rating and 6,900p target price on British-Swedish pharmaceutical outfit AstraZeneca on Monday.

29 Apr 19 11:17

AstraZeneca Gets European Ok For Lynparza As Ovarian Cancer Treatment

LONDON (Alliance News) - AstraZeneca PLC and Merck & Co have secured positive opinion for Lynparza as ovarian cancer treatment from the Committee for Medicinal Products for Human Use of the is

29 Apr 19 08:43

EU endorses wider use of AstraZeneca cancer drug

(Sharecast News) - AstraZeneca's ovarian cancer drug Lynparza on Monday received an endorsement from the European Medicines Agency, where a committee approved it to be used as a first-line maintenance treatment.

29 Apr 19 07:30

LONDON MARKET OPEN: RBS And Just Eat Slip; Computacenter Climbs

LONDON (Alliance News) - Stock prices in London opened in the red on Friday, with Royal Bank of Scotland slipping after a drop in income and a warning over the impact of dipped a

26 Apr 19 08:42

LONDON MARKET PRE-OPEN: RBS Profit Slips; AstraZeneca Starts 2019 Well

LONDON (Alliance News) - Stock prices in London are set for a slightly higher open on Friday, as Royal Bank of Scotland warned Brexit could affect future growth amid a busy for IG

26 Apr 19 07:37

AstraZeneca sees product sales rise 10pc in first quarter

(Sharecast News) - AstraZeneca reported a 10% increase in its product sales in its first quarter on Friday, or 14% at constant exchange rates, to $5.47bn.

26 Apr 19 07:23

Friday preview: US Q1 GDP, RBS in focus

(Sharecast News) - Barring surprises, the market spotlight at the end of the week will continue to be on the States, where the Department of Commerce is expected to publish a preliminary reading on first quarter GDP (consensus: 1.8%).

25 Apr 19 14:44

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.